Group 1 - LifeStance Health Group (LFST) closed at $6.80, with a 2.4% gain over the past four weeks, and a mean price target of $8.75 suggests a 28.7% upside potential [1] - The average price targets range from a low of $7 to a high of $10, with a standard deviation of $1.07, indicating variability among analysts' estimates [2] - Analysts show strong agreement on LFST's ability to report better earnings than previously predicted, which supports the potential for stock upside [4][11] Group 2 - The Zacks Consensus Estimate for LFST has increased by 2.5% due to one upward revision in earnings estimates over the last 30 days, with no negative revisions [12] - LFST holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for near-term upside [13] - While consensus price targets may not be entirely reliable, the implied direction of price movement appears to be a good guide for potential stock performance [13]
Wall Street Analysts Believe LifeStance Health (LFST) Could Rally 28.68%: Here's is How to Trade